These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36610823)

  • 1. Cerebrospinal fluid biomarkers in SARS-CoV-2 patients with acute neurological syndromes.
    Chaumont H; Kaczorowski F; San-Galli A; Michel PP; Tressières B; Roze E; Quadrio I; Lannuzel A
    Rev Neurol (Paris); 2023 Mar; 179(3):208-217. PubMed ID: 36610823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral Antigen and Inflammatory Biomarkers in Cerebrospinal Fluid in Patients With COVID-19 Infection and Neurologic Symptoms Compared With Control Participants Without Infection or Neurologic Symptoms.
    Edén A; Grahn A; Bremell D; Aghvanyan A; Bathala P; Fuchs D; Gostner J; Hagberg L; Kanberg N; Kanjananimmanont S; Lindh M; Misaghian S; Nilsson S; Schöll M; Sigal G; Stentoft E; Studahl M; Yilmaz A; Wang M; Stengelin M; Zetterberg H; Gisslén M
    JAMA Netw Open; 2022 May; 5(5):e2213253. PubMed ID: 35604688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in the Diagnosis of SARS-CoV-2 Infection in the Nervous System.
    Da Silva SJ; Cabral-Castro MJ; Gonçalves CCA; Mariani D; Ferreira O; Tanuri A; Puccioni-Sohler M
    Viruses; 2024 Aug; 16(8):. PubMed ID: 39205221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid analysis in patients with COVID-19-associated central nervous system manifestations: a systematic review.
    Domingues RB; Leite FBVM; Senne C
    Arq Neuropsiquiatr; 2022 Mar; 80(3):296-305. PubMed ID: 35239818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID-19 and associated with neurological symptoms and disease severity.
    Virhammar J; Nääs A; Fällmar D; Cunningham JL; Klang A; Ashton NJ; Jackmann S; Westman G; Frithiof R; Blennow K; Zetterberg H; Kumlien E; Rostami E
    Eur J Neurol; 2021 Oct; 28(10):3324-3331. PubMed ID: 33369818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease development.
    Espíndola OM; Brandão CO; Gomes YCP; Siqueira M; Soares CN; Lima MASD; Leite ACCB; Torezani G; Araujo AQC; Silva MTT
    Int J Infect Dis; 2021 Jan; 102():155-162. PubMed ID: 33127503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF Biomarkers in COVID-19 Associated Encephalopathy and Encephalitis Predict Long-Term Outcome.
    Guasp M; Muñoz-Sánchez G; Martínez-Hernández E; Santana D; Carbayo Á; Naranjo L; Bolós U; Framil M; Saiz A; Balasa M; Ruiz-García R; Sánchez-Valle R;
    Front Immunol; 2022; 13():866153. PubMed ID: 35479062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms: A Case Series.
    Edén A; Kanberg N; Gostner J; Fuchs D; Hagberg L; Andersson LM; Lindh M; Price RW; Zetterberg H; Gisslén M
    Neurology; 2021 Jan; 96(2):e294-e300. PubMed ID: 33004602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromes.
    Paterson RW; Benjamin LA; Mehta PR; Brown RL; Athauda D; Ashton NJ; Leckey CA; Ziff OJ; Heaney J; Heslegrave AJ; Benedet AL; Blennow K; Checkley AM; Houlihan CF; Mummery CJ; Lunn MP; Manji H; Zandi MS; Keddie S; Chou M; Vinayan Changaradil D; Solomon T; Keshavan A; Barker S; Jäger HR; Carletti F; Simister R; Werring DJ; Spyer MJ; Nastouli E; Gauthier S; Rosa-Neto P; ; Zetterberg H; Schott JM
    Brain Commun; 2021; 3(3):fcab099. PubMed ID: 34396099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Encephalitis Is a Cytokine Release Syndrome: Evidences From Cerebrospinal Fluid Analyses.
    Pilotto A; Masciocchi S; Volonghi I; De Giuli V; Caprioli F; Mariotto S; Ferrari S; Bozzetti S; Imarisio A; Risi B; Premi E; Benussi A; Focà E; Castelli F; Zanusso G; Monaco S; Stefanelli P; Gasparotti R; Zekeridou A; McKeon A; Ashton NJ; BlennoW K; Zetterberg H; Padovani A
    Clin Infect Dis; 2021 Nov; 73(9):e3019-e3026. PubMed ID: 33395482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis.
    Constantinescu R; Krýsl D; Bergquist F; Andrén K; Malmeström C; Asztély F; Axelsson M; Menachem EB; Blennow K; Rosengren L; Zetterberg H
    Eur J Neurol; 2016 Apr; 23(4):796-806. PubMed ID: 26822123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations.
    Bonetto V; Pasetto L; Lisi I; Carbonara M; Zangari R; Ferrari E; Punzi V; Luotti S; Bottino N; Biagianti B; Moglia C; Fuda G; Gualtierotti R; Blasi F; Canetta C; Montano N; Tettamanti M; Camera G; Grimoldi M; Negro G; Rifino N; Calvo A; Brambilla P; Biroli F; Bandera A; Nobili A; Stocchetti N; Sessa M; Zanier ER
    Front Immunol; 2022; 13():1070379. PubMed ID: 36591311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid in COVID-19 neurological complications: Neuroaxonal damage, anti-SARS-Cov2 antibodies but no evidence of cytokine storm.
    Garcia MA; Barreras PV; Lewis A; Pinilla G; Sokoll LJ; Kickler T; Mostafa H; Caturegli M; Moghekar A; Fitzgerald KC; ; Pardo CA
    J Neurol Sci; 2021 Aug; 427():117517. PubMed ID: 34090021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of serum and cerebrospinal fluid biomarkers after vaccination against SARS-CoV-2.
    Iacono S; Piccoli T; Aridon P; Schirò G; Blandino V; Tarantino D; Agnello L; Ciaccio M; Ragonese P; Salemi G
    Ann Clin Transl Neurol; 2023 Jun; 10(6):1025-1034. PubMed ID: 37139906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal Fluid Neurofilament Light Chain Is Associated with Kynurenine Pathway Metabolite Changes in Multiple Sclerosis.
    Rajda C; Galla Z; Polyák H; Maróti Z; Babarczy K; Pukoli D; Vécsei L
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum of hospitalized NeuroCOVID diagnoses from a tertiary care neurology centre in Eastern India.
    Bhansali S; Bagrodia V; Choudhury S; Rahman S; Golder M; Tiwari M; Kumar H
    J Clin Neurosci; 2021 Nov; 93():96-102. PubMed ID: 34656269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis.
    Mariotto S; Gajofatto A; Zuliani L; Zoccarato M; Gastaldi M; Franciotta D; Cantalupo G; Piardi F; Polo A; Alberti D; Sartori S; Zanusso G; Agrò L; Demurtas R; Sechi G; Sechi E; Monaco S; Ferrari S
    J Neurol; 2019 Jul; 266(7):1643-1648. PubMed ID: 30944980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients.
    Alexopoulos H; Magira E; Bitzogli K; Kafasi N; Vlachoyiannopoulos P; Tzioufas A; Kotanidou A; Dalakas MC
    Neurol Neuroimmunol Neuroinflamm; 2020 Nov; 7(6):. PubMed ID: 32978291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal Fluid Features in Patients With Coronavirus Disease 2019 and Neurological Manifestations: Correlation with Brain Magnetic Resonance Imaging Findings in 58 Patients.
    Lersy F; Benotmane I; Helms J; Collange O; Schenck M; Brisset JC; Chammas A; Willaume T; Lefebvre N; Solis M; Hansmann Y; Fabacher T; Caillard S; Mertes PM; Pottecher J; Schneider F; Meziani F; Fafi-Kremer S; Kremer S
    J Infect Dis; 2021 Feb; 223(4):600-609. PubMed ID: 33249438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid cytokine, chemokine, and SARS-CoV-2 antibody profiles in children with neuropsychiatric symptoms associated with COVID-19.
    Ngo B; Lapp SA; Siegel B; Patel V; Hussaini L; Bora S; Philbrook B; Weinschenk K; Wright L; Anderson EJ; Rostad CA; Gombolay GY
    Mult Scler Relat Disord; 2021 Oct; 55():103169. PubMed ID: 34333272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.